Skip to main content
Caplight Logo









Invero Pharma

Invero Pharma

Private
Buffalo, New YorkHealthcare & Life Scienceshttps://inveropharma.com/

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Invero Pharma is a clinical-stage biopharmaceutical company that develops neuroprotective therapies for acute brain injuries using its proprietary XENEX xenon gas-based inhalation technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

neuroprotective therapytraumatic brain injuryTBIxenon gas therapycritical care medical devicebiopharmaceuticalclinical-stage biotechmedical gas deliveryacute brain injuryNMDA receptor modulatorpost-cardiac arrest syndromeorphan drugneuro-critical carebrain trauma treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Invero Pharma Comparables

Compare Invero Pharma with similar companies based on industry and business-model similarity.

Invero Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rheos Medical Corp.
81%

Invero Pharma Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Matt Napoletano

COO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 115% MoM.

  • May 4, 2025

    Monthly visitors grew 501% MoM, reaching 1.9K.

Invero Pharma Filings

Explore SEC and related filing metadata, where available.

Invero Pharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Invero Pharma's valuation, stock price, and market status.

Is Invero Pharma a public or private company?

Invero Pharma is a private company.

What is the current stock price of Invero Pharma?

Invero Pharma is a private company, so its shares have no public market price. Caplight tracks Invero Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Invero Pharma worth (valuation)?

Valuation information for Invero Pharma is not publicly available.

Can I buy Invero Pharma stock?

Invero Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Invero Pharma's last funding round?

Funding round information for Invero Pharma is not publicly available.

Who are the main investors in Invero Pharma?

Investor information for Invero Pharma is not publicly disclosed.

Will Invero Pharma IPO soon?

No public IPO plans have been announced for Invero Pharma.

How can I track Invero Pharma secondary market activity?

Caplight tracks bids, offers, and trades in Invero Pharma's shares on secondary markets.

Firmographic Details

HeadquartersBuffalo, New York
Employee Range3
Year FoundedN/A
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?